Turn Therapeutics (TTRX) Non Operating Income (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly Non Operating Income of $275171.0 in Q1 2026, down 76.35% quarter-over-quarter from $1.2 million in Q4 2025, and up 387.46% on a YoY basis from $56450.0 in Q1 2025.
Turn Therapeutics (TTRX) Non Operating Income (2024 - 2026) Analysis & Trends
Turn Therapeutics' Non Operating Income history runs 3 years deep, the most recent figure standing at $275171.0 for Q1 2026.
- In Q1 2026, Non Operating Income rose 387.46% year-over-year to $275171.0; the TTM figure through Mar 2026 stood at $1.5 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, up 54.57% from the prior year.
- Non Operating Income was $275171.0 for Q1 2026 at Turn Therapeutics, down from $1.2 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.2 million in Q4 2025 to a low of $6550.0 in Q3 2024.
- Historically, Non Operating Income has averaged $392543.7 across 3 years, with a median of $165810.5 in 2025.
- The sharpest annual moves came in 2025 and 2026: Non Operating Income surged 37.85% in 2025, then surged 387.46% in 2026.
- A 3-year view of Non Operating Income shows it stood at $844102.0 in 2024, then soared by 37.85% to $1.2 million in 2025, then slumped by 76.35% to $275171.0 in 2026.
- The last three Non Operating Income figures came in at $275171.0 (Q1 2026), $1.2 million (Q4 2025), and $9371.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Turn Therapeutics | 175.38 Mn | 175.38 Mn | - | 275,171.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 275,171.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 9,371.00 |
| Mar 31, 2025 | 56,450.00 |
| Dec 31, 2024 | 844,102.00 |
| Sep 30, 2024 | 6,550.00 |